CAMP PODS is a webinar series, consisting of 10 one-hour sessions that will take place from January to November 2021 on the 1st Thursday of each month with the exception of our first session, which will take place on January 14th.
The goal of this series is to build a strong Oncology Laboratory Medicine community, where best practices and common challenges can be discussed. Insights gained will be key to implement across Canada and will help streamline laboratory workflows and practice for laboratory medicine, the end result of which will be improvements in the patient journey.
Overall Learning Objectives:
By the end of the webinar series, an audience member will:
- Establish a strong Oncology Education Network
- Compare ideas, thoughts and common challenges
- Identify gaps and find team solutions for improving patient care
- Integrate pathology and oncology practices
AGENDA
All recorded sessions are password protected. If you don’t have a password, please contact charmaine@haymatick.com to get access to CAMPPOD recordings.
Thursday, January 14th, 2021 – Access the Virtual Conference Recorded SessionChair: Dr. Diana Ionescu |
||
| 10:00am – 10:30am PST | Deep Learning in Pathology – Connecting Morphology with Genome | Dr. Stephen Yip |
| 10:30am – 11:00am PST | Questions & Answers | |
| Presentation Learning Objectives: As a result of attending this session the participant will be able to: 1. Understand the fundamentals as well as evolving concept of deep learning 2. Appreciate the potentials of deep learning in medicine and particularly in the practice of pathology 3. Build a Deep learning- integrative academic pathology program |
||
Thursday, February 4, 2021 – Access the Virtual Conference Recorded SessionChair: Dr. Diana Ionescu |
||
| 10:00am – 10:30am PST | Molecular Subtyping of Urothelial Carcinoma: Pathological Correlation and Clinical Impact | Dr. Peter Black & Dr. Gang Wang |
| 10:30am – 11:00am PST | Questions & Answers | |
| Presentation Learning Objectives: As a result of attending this session the participant will be able to:
|
||
Thursday, March 4, 2021 – Access the Virtual Conference Recorded SessionChair: Dr. Diana Ionescu |
||
| 10:00am – 10:30am PST | Nurse Navigator in Oncology: Luxury or Necessity? | Ms. Kelly Zibrik |
| 10:30am – 11:00am PST | Questions & Answers | |
| Presentation Learning Objectives: As a result of attending this session the participant will be able to: 1. Describe the role of the Nurse Navigator in thoracic oncology at BC Cancer Vancouver. 2. Recognize current challenges in triage workflow in relation to pathology practice. 3. Specify opportunities for improving molecular-biomarker turnaround times for cancer patients. 4. Identify key actions that pathologists can do to improve patient triage in oncology. |
||
Thursday, May 6, 2021 – Access the Virtual Conference Recorded SessionChair: Dr. Diana Ionescu |
||
| 10:00am – 10:30am PST | Fast Forward to Finding and Treating Fusions (with a focus on Colorectal Cancers) | Dr. Eric Chen & Dr. Jaclyn Hechtman |
| 10:30am – 11:00am PST | Questions & Answers | |
| Presentation Learning Objectives: As a result of attending this session the participant will be able to: 1. Describe the frequency of NTRK fusions across cancers 2. Understand molecular subtype of colorectal carcinoma enriched in kinase fusions 3. List and compare methods of detecting NTRK fusions 4. Share Canadian experiences in treating patients with NTRK fusion-positive colorectal cancer. |
||
Thursday, June 3, 2021 – Access the Virtual Conference Recorded SessionChair: Dr. Diana Ionescu |
||
| 11:00am – 11:30am PST | Update on First-Line Immunotherapy and PD-L1 Testing in HNSCC | Dr. Denis Soulières |
| 11:30am – 12:00pm PST | Questions & Answers | |
| Presentation Learning Objectives: 1. Identify key points on the selection of therapy in the first-line setting in R/M HNSCC 2. Understand the value of PD-L1 testing in this setting 3. Specify unmet medical needs for this population |
||
Thursday, August 5, 2021 – Access the Virtual Conference Recorded SessionChair: Dr. Diana Ionescu |
||
| 10:00am – 10:30am PST | ASCO 2021 Pathology Needed for Adjuvant Therapy | Dr. Barb Melosky & |
| 10:30am – 11:00am PST | Questions & Answers | |
| Presentation Learning Objectives: 1. Review current management of resected NSCLC 2. Discuss the recent data of adjuvant EGFR-TKI use in resected patients 3. Explore updates from ASCO 2021 on adjuvant EGFR TKI studies and for Wild Type patients |
||
Thursday, September 2, 2021 – Access the Virtual Conference Recorded SessionChair: Dr. Diana Ionescu |
||
| 10:00am – 10:30am PST | Personalized Treatment Strategies in Metastatic Colorectal Cancer | Dr. Sharlene Gill |
| 10:30am – 11:00am PST | Questions & Answers | |
| Presentation Learning Objectives: 1. To review the current management of metastatic colorectal cancer
2. To review the established biomarker driven approaches for the treatment of metastatic colorectal cancer
3. To discuss the role of testing strategies and emerging biomarkers in CRC
|
||
Thursday, October 7, 2021 – Access the Virtual Conference Recorded SessionChair: Dr. Diana Ionescu |
||
| 10:00am – 10:30am PST | Interpretation of Residual Cancer After Neoadjuvant Treatment for Breast Cancer | Dr. W. Fraser Symmans |
| 10:30am – 11:00am PST | Questions & Answers | |
| Presentation Learning Objectives: 1. Learn how to measure and report residual disease after neoadjuvant treatment 2. Understand the prognostic meaning of response to neoadjuvant treatment 3. Understand the relevance of response in the context of molecular subtypes of disease and in the context of contemporary treatment planning |
||
Thursday, November 4, 2021Chair: Dr. Diana Ionescu |
||
| 10:00am – 10:30am PST | Novel Biomarkers | TBD |
| 10:30am – 11:00am PST | Questions & Answers | |
| Presentation Learning Objectives: | ||
Thursday, December 2, 2021Chair: Dr. Diana Ionescu |
||
| 10:00am – 10:30am PST | Presentation | TBD |
| 10:30am – 11:00am PST | Questions & Answers | |
| Presentation Learning Objectives: | ||